Not Signed In - Procter & Gamble Pharmaceuticals Commemorates 15 Years Of Trusted Leadership With Asacol(R) (Mesalamine) Delayed-Release Tablets
Fri, 02 Feb 2007 08:00 AM EST
... Procter & Gamble Pharmaceuticals, Inc. today celebrates the trusted efficacy of Asacol on its 15th anniversary. Asacol is the No. 1 most prescribed 5-ASA therapy for ulcerative colitis (UC), a form of inflammatory bowel disease (IBD).(1) More than 20 million prescriptions have been written for Asacol since it was approved by the U.S. Food and Drug Administration and launched in 1992. [click link for full article] ...
Related Topics
- Mesalamine Oral
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
- Didanosine Delayed Release Capsule
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Zinc Salts tablets or capsules
- Carbinoxamine and Pseudoephedrine Tablets
- CA 15-3
- Isradipine Extended-Release Tablets
- Mesalamine
- Cyanocobalamin Tablets
- Duloxetine
- Death And Dying
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Neostigmine Tablets
- Haloperidol Tablets
- Thiabendazole Tablets
- Delayed Gastric Emptying (Gastroparesis)
- Mesalamine Rectal
email this page
print this page
bookmark this page
feedback on this page
